Beranda › Infeksi Virus Respiratory Syncytial › California
Uji klinis Infeksi Virus Respiratory Syncytial di California
5 studi untuk Infeksi Virus Respiratory Syncytial mencari peserta di lokasi di California.
Teks studi resmi (Bahasa Inggris)
Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
- City of Hope Comprehensive Cancer Center, Duarte
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06817889A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
- LA Universal Research Center, Inc., Los Angeles
- Central Valley Research, Modesto
- Med Partnes, Inc - Elligo- PPDS, Toluca Lake
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07214571A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
- Ronald Reagan UCLA Medical Center, Los Angeles
- Ronald Reagan UCLA Medical Center (inpatient hospital), Los Angeles
- Ronald Reagan UCLA Medical Center, Los Angeles
- dan 7 lainnya
Menerima pesertaFase 3Sukarelawan sehat diterima
Usia 0 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06866405A Study of BLB-201 RSV Vaccine in Infants and Children
- Paradigm Clinical Research, La Mesa
- Paradigm Clinical Research - Modesto, Modesto
- University of California, San Diego, San Diego
Menerima pesertaFase 1/2Sukarelawan sehat diterima
6 Months – 5 Years · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT05655182Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
- University of California San Francisco, San Francisco
Menerima pesertaFase 3
3 Days – 2 Years · Semua jenis kelamin · Diperbarui 9 Feb 2026 · NCT05026749Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.